期刊
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
卷 40, 期 7, 页码 279-286出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urolonc.2020.01.019
关键词
Bladder cancer; Mutation; Mutation signature; APOBEC; Genomics
资金
- Jesse Brown VA Medical Center, Chicago, IL [BX003692]
- John P. Hanson Foundation for Cancer Research (Milwaukee, WI)
This review discusses the full spectrum of the genomic landscape of muscle-invasive bladder cancer (MIBC) toward the goal of therapeutic application.
The Cancer Genome Atlas (TCGA) for bladder cancer was published in 2014 with updated annotation of over 400 patients with muscle-invasive bladder cancer (MIBC) in 2017. This tremendous work established the foundation of the genomic landscape of MIBC. The next steps to utilize information from The Cancer Genome Atlas is to (1) identify the causes of mutation, (2) determine the significant differences and sources of heterogeneity, and (3) apply these tools toward patient care. In this review, we discuss the full spectrum of the genomic landscape of MIBC toward the goal of therapeutic application. (C) 2020 Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据